Suresh Gadde

Dr. Suresh Gadde is an Assistant Professor in the Department of Biochemistry, Microbiology and Immunology at the University of Ottawa's Faculty of Medicine. His research focuses on developing innovative nanomedicine approaches for treating cancer, atherosclerosis, and inflammatory diseases. Gadde designs multifunctional nanoparticle systems for targeted drug delivery, gene therapy, and combination therapies, with emphasis on overcoming biological barriers to improve treatment efficacy.

His work spans multiple disciplines including biomaterials science, molecular biology, and translational medicine. Key research areas include RNA-based nanotherapies, nanoparticle-mediated drug delivery systems, inflammation resolution strategies, and novel approaches for cancer treatment using nanoplatforms to simultaneously target tumor cells, cancer stem cells, and tumor vasculature.

Gadde's recent publications demonstrate a strong focus on advancing nanoparticle applications for challenging medical conditions. His work on SARS-CoV-2 viral mechanisms provides foundational insights for antiviral development. The therapeutic strategies developed in his lab show promising applications across oncology, cardiology, and virology.